PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.

DEFINITIVE CONTRACT won by REGENERON PHARMACEUTICALS INC · work in TARRYTOWN, NY
$5,565,000,000
RecipientREGENERON PHARMACEUTICALS INC UEI N3F9MH7E6HD6
Award IDW15QKN21C0014
Award amount$5,565,000,000
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Defense — Department of the Army
NAICS325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC6505
Set-asideUnrestricted
Start dateJan 12, 2021
End dateJul 31, 2022
Place of performanceTARRYTOWN, NY
Record updatedApr 22, 2025

View the official award record

More awards won by REGENERON PHARMACEUTICALS INC

IGF::OT::IGF
Department of Health and Human Services · $973,560,407 · Sep 30, 2017
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Department of Health and Human Services · $278,844,172 · Sep 21, 2017
IGF::OT::IGF
Department of Health and Human Services · $8,601,629 · Aug 9, 2016
EVKEEZA DRUG
Department of Veterans Affairs · $494,095 · Nov 24, 2021

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids